Evidence map›Paper›PMID 40699644›Full record

ArticleCurrent issues in molecular biology2025

B Cell Dynamics and Transitional B Cells in Long COVID.

Zoia R Korobova, Natalia A Arsentieva, Natalia E Liubimova, Oleg K Batsunov, Anastasia A Butenko, Albina E Kokoeva, Natalia G Kucherenko, Victor A Kashchenko, Ekaterina V Boeva, Anna O Norka and 4 more

Abstract read
In one paragraph

Article in Current issues in molecular biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. T Cell Dynamics in COVID-19, Long COVID and Successful Recovery.International journal of molecular sciences · 2025
    Article
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Zoia R KorobovaLaboratory of Molecular Immunology, Saint Petersburg Pasteur Institute, ul. Mira, 14, 197101 Saint Petersburg, Russia.ORCID 0000-0003-0535-5014
Natalia A ArsentievaLaboratory of Molecular Immunology, Saint Petersburg Pasteur Institute, ul. Mira, 14, 197101 Saint Petersburg, Russia.
Natalia E LiubimovaLaboratory of Molecular Immunology, Saint Petersburg Pasteur Institute, ul. Mira, 14, 197101 Saint Petersburg, Russia.
Oleg K BatsunovLaboratory of Molecular Immunology, Saint Petersburg Pasteur Institute, ul. Mira, 14, 197101 Saint Petersburg, Russia.
Anastasia A ButenkoLaboratory of Molecular Immunology, Saint Petersburg Pasteur Institute, ul. Mira, 14, 197101 Saint Petersburg, Russia.
Albina E KokoevaThe Federal State Budgetary Institution 'North-Western District Scientific and Clinical Center Named after L.G. Sokolov Federal Medical and Biological Agency', Prospekt Kul'tury, 4, 194291 Saint Petersburg, Russia.
Natalia G KucherenkoThe Federal State Budgetary Institution 'North-Western District Scientific and Clinical Center Named after L.G. Sokolov Federal Medical and Biological Agency', Prospekt Kul'tury, 4, 194291 Saint Petersburg, Russia.
Victor A KashchenkoThe Federal State Budgetary Institution 'North-Western District Scientific and Clinical Center Named after L.G. Sokolov Federal Medical and Biological Agency', Prospekt Kul'tury, 4, 194291 Saint Petersburg, Russia.ORCID 0000-0002-4958-5850
Ekaterina V BoevaLaboratory of Molecular Immunology, Saint Petersburg Pasteur Institute, ul. Mira, 14, 197101 Saint Petersburg, Russia.
Anna O NorkaLaboratory of Molecular Immunology, Saint Petersburg Pasteur Institute, ul. Mira, 14, 197101 Saint Petersburg, Russia.
Anastasia A KnizhnikovaLaboratory of Molecular Immunology, Saint Petersburg Pasteur Institute, ul. Mira, 14, 197101 Saint Petersburg, Russia.
Vadim V RassokhinLaboratory of Molecular Immunology, Saint Petersburg Pasteur Institute, ul. Mira, 14, 197101 Saint Petersburg, Russia.
Nikolay A BelyakovLaboratory of Molecular Immunology, Saint Petersburg Pasteur Institute, ul. Mira, 14, 197101 Saint Petersburg, Russia.
Areg A TotolianLaboratory of Molecular Immunology, Saint Petersburg Pasteur Institute, ul. Mira, 14, 197101 Saint Petersburg, Russia.ORCID 0000-0003-4571-8799

Funding

Federal Service on Customers' Rights Protection and Human Well-Being Surveillance of Russia 121030200299-3
6 · The paper itself

Abstract

backgroundLong COVID is characterized by persistent symptoms following acute SARS-CoV-2 infection. This study aims to evaluate immune system markers, including antigen-specific antibodies, B cell subsets, and Th2-related cytokines, in individuals with long COVID and to investigate their potential impact on the development of this condition.

methodsWe analyzed blood plasma from 63 individuals diagnosed with long COVID based on clinical presentation and 47 healthy individuals with COVID-19 history but no clinical symptoms. Antigen-specific IgG antibodies were measured using commercial ELISA kits. Lymphocyte subpopulations were assessed via flow cytometry and a gating strategy based on CD27 and CD38. Th2 cytokines (IL-4, IL-5, IL-13) were quantified using the xMAP multiplex assay.

resultsWe noted no significant differences in IgG levels between groups. Notably, individuals with long COVID demonstrated a higher percentage of naive mature B cells (CD27-CD38+), while transitional (CD27-CD38+++) and double-negative (DN, CD27-CD38-) cells were significantly reduced. Elevated levels of IL-5 and IL-13 were observed in long COVID patients. Classification analysis revealed that the percentage of transitional B cells (CD27-CD38+++) was a strong predictor of long COVID.

conclusionsOur findings highlight alterations in B cell dynamics among individuals with long COVID, which may contribute to autoimmune processes.

Indexed as

B cellsCD27CD38cytokineslong COVIDTh2transitional B cells

Identifiers

PMID40699644
PMCPMC12026000

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.